Chun Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chun Fang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hua-Qiao Tan
Department of Interventional Radiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
2 shared publications Jue Wang
Affiliated to Shanghai Jiao Tong University
2 shared publicationsMing-Hua Li
Affiliated to Shanghai Jiao Tong University
2 shared publicationsWu Wang
Affiliated to Shanghai Jiao Tong University
2 shared publicationsYing-Sheng Cheng
Affiliated to Shanghai Jiao Tong University
2 shared publicationsYue-Qi Zhu
Affiliated to Shanghai Jiao Tong University
2 shared publications
Latest Publications
- Open Access
- 22 July 2009
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 151 (11) , 1563
Trans-arterial embolisation therapy of dural carotid-cavernous fistulae using low concentration n-butyl-cyanoacrylate
- 22 July 2009
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 151 (11) , 1563
Open AccessTrans-arterial embolisation therapy of dural carotid-cavernous fistulae using low concentration n-butyl-cyanoacrylate
- 29 October 2008
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 150 (11) , 1149-1156
Trans-arterial embolisation therapy of dural carotid–cavernous fistulae using low concentration n-butyl-cyanoacrylate
Trans-venous embolisation has been accepted as the preferred treatment for dural carotid–cavernous fistulae (DCCF). However, such an approach is not always feasible. In this circumstance, trans-arterial embolisation with low concentration n-butyl-cyanoacrylate glue (NBCA) may be a feasible alternative. We report our results and experience of this method for DCCF. Five patients with DCCF were treated by trans-arterial embolisation using low concentration NBCA by wedging the microcatheter into the main feeding artery. All five lesions were associated with venous drainage into the superior ophthalmic vein. The inferior petrosal sinus was patent in one patient and thrombosed in four. Additional venous drainage into the Sylvian vein and the superior petrosal sinus was observed in two patients. The definitive NBCA injection was performed via the branches of the middle meningeal artery in three patients and accessory meningeal artery as well as ascending pharyngeal artery in two patients. Four patients showed complete obliteration of the DCCF on the post-embolisation angiogram, and follow-up studies showed clinical cure or improvement and successful obliteration of the DCCF. One patient had a residual DCCF after the procedure, but showed complete obliteration and clinical cure at 5-month follow-up. Glue penetrated into the Sylvian vein in one patient during the procedure without sequelae. Two patients had transient worsening of ocular symptoms after the procedure. Trans-arterial embolisation with low concentration NBCA using a wedged microcatheter technique is still a safe and effective treatment for DCCF when the transvenous approach is not feasible. However, care must be taken to prevent inadvertent arterial and venous embolisation.
- 29 October 2008
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 150 (11) , 1149-1156
Trans-arterial embolisation therapy of dural carotid–cavernous fistulae using low concentration n-butyl-cyanoacrylate
Trans-venous embolisation has been accepted as the preferred treatment for dural carotid–cavernous fistulae (DCCF). However, such an approach is not always feasible. In this circumstance, trans-arterial embolisation with low concentration n-butyl-cyanoacrylate glue (NBCA) may be a feasible alternative. We report our results and experience of this method for DCCF. Five patients with DCCF were treated by trans-arterial embolisation using low concentration NBCA by wedging the microcatheter into the main feeding artery. All five lesions were associated with venous drainage into the superior ophthalmic vein. The inferior petrosal sinus was patent in one patient and thrombosed in four. Additional venous drainage into the Sylvian vein and the superior petrosal sinus was observed in two patients. The definitive NBCA injection was performed via the branches of the middle meningeal artery in three patients and accessory meningeal artery as well as ascending pharyngeal artery in two patients. Four patients showed complete obliteration of the DCCF on the post-embolisation angiogram, and follow-up studies showed clinical cure or improvement and successful obliteration of the DCCF. One patient had a residual DCCF after the procedure, but showed complete obliteration and clinical cure at 5-month follow-up. Glue penetrated into the Sylvian vein in one patient during the procedure without sequelae. Two patients had transient worsening of ocular symptoms after the procedure. Trans-arterial embolisation with low concentration NBCA using a wedged microcatheter technique is still a safe and effective treatment for DCCF when the transvenous approach is not feasible. However, care must be taken to prevent inadvertent arterial and venous embolisation.